Nollaig Forrest Acquires 2,000 Shares of Amrize (NYSE:AMRZ) Stock

Amrize Ltd (NYSE:AMRZGet Free Report) insider Nollaig Forrest bought 2,000 shares of Amrize stock in a transaction on Friday, May 22nd. The shares were bought at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the acquisition, the insider owned 20,139 shares of the company’s stock, valued at approximately $1,011,984.75. The trade was a 11.03% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Amrize Stock Performance

Shares of AMRZ stock opened at $53.13 on Thursday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The stock has a market cap of $29.39 billion and a PE ratio of 25.42. The stock has a 50-day moving average of $54.51 and a 200-day moving average of $55.13. Amrize Ltd has a one year low of $44.12 and a one year high of $65.94.

Amrize (NYSE:AMRZGet Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The firm had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The business’s revenue for the quarter was up 4.7% on a year-over-year basis. As a group, sell-side analysts expect that Amrize Ltd will post 2.76 earnings per share for the current year.

Amrize Cuts Dividend

The company also recently declared a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is currently 21.05%.

Wall Street Analyst Weigh In

AMRZ has been the topic of several research analyst reports. Wall Street Zen raised Amrize from a “sell” rating to a “hold” rating in a research note on Sunday, March 1st. Weiss Ratings cut Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 18th. JPMorgan Chase & Co. increased their price target on Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a report on Thursday, March 5th. Truist Financial cut their price objective on Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Finally, Citigroup decreased their price objective on Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a research report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Amrize has a consensus rating of “Moderate Buy” and a consensus price target of $64.86.

View Our Latest Stock Report on Amrize

Hedge Funds Weigh In On Amrize

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MCF Advisors LLC acquired a new stake in shares of Amrize in the 4th quarter valued at about $27,000. Basepoint Wealth LLC acquired a new position in shares of Amrize during the fourth quarter worth about $33,000. Laurel Wealth Advisors LLC bought a new position in shares of Amrize during the fourth quarter worth about $34,000. State of Wyoming bought a new position in shares of Amrize during the third quarter worth about $32,000. Finally, Itau Unibanco Holding S.A. raised its position in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after buying an additional 450 shares during the last quarter.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.